These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 36632973

  • 1. Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid.
    Ding D, Ren P, Guo G, Liu Y, Yang C, Zheng L, Jia G, Deng J, Sun R, Wang X, Zhou X, Shang Y, Han Y.
    Gastroenterol Hepatol; 2023 Nov; 46(9):692-701. PubMed ID: 36632973
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid.
    Ding D, Guo G, Liu Y, Zheng L, Jia G, Deng J, Sun R, Wang X, Guo C, Shang Y, Han Y.
    Hepatol Commun; 2022 Dec; 6(12):3487-3495. PubMed ID: 36213941
    [Abstract] [Full Text] [Related]

  • 3. Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
    Hegade VS, Khanna A, Walker LJ, Wong LL, Dyson JK, Jones DEJ.
    Dig Dis Sci; 2016 Oct; 61(10):3037-3044. PubMed ID: 27435324
    [Abstract] [Full Text] [Related]

  • 4. Additional fibrate treatment in UDCA-refractory PBC patients.
    Chung SW, Lee JH, Kim MA, Leem G, Kim SW, Chang Y, Lee HY, Yoon JS, Park JY, Lee YB, Cho EJ, Yu SJ, Kim YJ, Yoon JH.
    Liver Int; 2019 Sep; 39(9):1776-1785. PubMed ID: 31162879
    [Abstract] [Full Text] [Related]

  • 5. Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes.
    Cheung AC, Lapointe-Shaw L, Kowgier M, Meza-Cardona J, Hirschfield GM, Janssen HL, Feld JJ.
    Aliment Pharmacol Ther; 2016 Jan; 43(2):283-93. PubMed ID: 26559762
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA.
    Duan W, Ou X, Wang X, Wang Y, Zhao X, Wang Q, Wu X, Zhang W, Ma H, You H, Jia J.
    Rev Esp Enferm Dig; 2018 Sep; 110(9):557-563. PubMed ID: 29739227
    [Abstract] [Full Text] [Related]

  • 7. Fenofibrate improves GLOBE and UK-PBC scores and histological features in primary biliary cholangitis.
    Wang L, Sun K, Tian A, Liu Y, Zhang M, Zhou X, Han Y.
    Minerva Med; 2022 Dec; 113(6):974-982. PubMed ID: 33949176
    [Abstract] [Full Text] [Related]

  • 8. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.
    Harms MH, van Buuren HR, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Hirschfield GM, Parés A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Lammers WJ, Hansen BE, van der Meer AJ.
    J Hepatol; 2019 Aug; 71(2):357-365. PubMed ID: 30980847
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis.
    Zhang Y, Li S, He L, Wang F, Chen K, Li J, Liu T, Zheng Y, Wang J, Lu W, Zhou Y, Yin Q, Xia Y, Zhou Y, Lu J, Guo C.
    Drug Des Devel Ther; 2015 Aug; 9():2757-66. PubMed ID: 26045661
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A Randomized Clinical Trial.
    Liu Y, Guo G, Zheng L, Sun R, Wang X, Deng J, Jia G, Yang C, Cui L, Guo C, Shang Y, Han Y.
    Am J Gastroenterol; 2023 Nov 01; 118(11):1973-1979. PubMed ID: 36892506
    [Abstract] [Full Text] [Related]

  • 11. Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis.
    Harms MH, de Veer RC, Lammers WJ, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Trivedi PJ, Hirschfield GM, Pares A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Hansen BE, Buuren HRV, van der Meer AJ.
    Gut; 2020 Aug 01; 69(8):1502-1509. PubMed ID: 31843787
    [Abstract] [Full Text] [Related]

  • 12. Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation.
    Montano-Loza AJ, Lytvyak E, Hirschfield G, Hansen BE, Ebadi M, Berney T, Toso C, Magini G, Villamil A, Nevens F, Van den Ende N, Pares A, Ruiz P, Terrabuio D, Trivedi PJ, Abbas N, Donato MF, Yu L, Landis C, Dumortier J, Dyson JK, van der Meer AJ, de Veer R, Pedersen M, Mayo M, Manns MP, Taubert R, Kirchner T, Belli LS, Mazzarelli C, Stirnimann G, Floreani A, Cazzagon N, Russo FP, Burra P, Zigmound U, Houri I, Carbone M, Mulinacci G, Fagiuoli S, Pratt DS, Bonder A, Schiano TD, Haydel B, Lohse A, Schramm C, Rüther D, Casu S, Verhelst X, Beretta-Piccoli BT, Robles M, Mason AL, Corpechot C, Global PBC Study Group.
    J Hepatol; 2024 Oct 01; 81(4):679-689. PubMed ID: 38821360
    [Abstract] [Full Text] [Related]

  • 13. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P, Pimentel S, Talwalkar JA, Enders FT, Lindor KD, Krom RA, Wiesner RH.
    Liver Transpl; 2007 Sep 01; 13(9):1236-45. PubMed ID: 17763401
    [Abstract] [Full Text] [Related]

  • 14. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
    Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB, Houben MH, Witteman BJ, van Erpecum KJ, van Buuren HR, Dutch PBC Study Group.
    Gastroenterology; 2009 Apr 01; 136(4):1281-7. PubMed ID: 19208346
    [Abstract] [Full Text] [Related]

  • 15. Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population.
    Cançado GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, Terrabuio DRB, Cançado ELR, Nardelli MJ, Faria LC, Gomes NMF, de Oliveira EMG, Rotman V, de Oliveira MB, da Cunha SMCF, Mazo DFC, Mendes LSC, Ivantes CAP, Codes L, de Almeida E Borges VF, Pace FHL, Pessoa MG, Signorelli IV, Coral GP, Bittencourt PL, Levy C, Couto CA, Members of the Brazilian Cholestasis Study Group Consortium.
    Ann Hepatol; 2022 Apr 01; 27(1):100546. PubMed ID: 34600142
    [Abstract] [Full Text] [Related]

  • 16. Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.
    Lemoinne S, Pares A, Reig A, Ben Belkacem K, Kemgang Fankem AD, Gaouar F, Poupon R, Housset C, Corpechot C, Chazouillères O.
    Clin Res Hepatol Gastroenterol; 2018 Dec 01; 42(6):521-528. PubMed ID: 30100231
    [Abstract] [Full Text] [Related]

  • 17. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
    Corpechot C, Abenavoli L, Rabahi N, Chrétien Y, Andréani T, Johanet C, Chazouillères O, Poupon R.
    Hepatology; 2008 Sep 01; 48(3):871-7. PubMed ID: 18752324
    [Abstract] [Full Text] [Related]

  • 18. Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators.
    Qian JD, Yao TT, Wang Y, Wang GQ.
    Clin Res Hepatol Gastroenterol; 2020 Nov 01; 44(6):874-884. PubMed ID: 32305248
    [Abstract] [Full Text] [Related]

  • 19. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.
    Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, Spicer A, Badrock J, Bernuzzi F, Cardinale V, Ainsworth HF, Heneghan MA, Thorburn D, Bathgate A, Jones R, Neuberger JM, Battezzati PM, Zuin M, Taylor-Robinson S, Donato MF, Kirby J, Mitchell-Thain R, Floreani A, Sampaziotis F, Muratori L, Alvaro D, Marzioni M, Miele L, Marra F, Giannini E, Gaudio E, Ronca V, Bonato G, Cristoferi L, Malinverno F, Gerussi A, Stocken DD, Cordell HJ, Hirschfield GM, Alexander GJ, Sandford RN, Jones DE, Invernizzi P, Mells GF, Italian PBC Study Group and the UK–PBC Consortium.
    Lancet Gastroenterol Hepatol; 2018 Sep 01; 3(9):626-634. PubMed ID: 30017646
    [Abstract] [Full Text] [Related]

  • 20. Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.
    de Veer RC, Harms MH, Corpechot C, Thorburn D, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lammers WJ, Hansen BE, van Buuren HR, van der Meer AJ, Global PBC Study Group.
    Aliment Pharmacol Ther; 2022 Nov 01; 56(9):1408-1418. PubMed ID: 36138566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.